Fonterra Co-operative Group Ltd (ASX:FSF) Reports Q1 Progress
Fonterra Co-operative Group Ltd (ASX:FSF) announces a strong Q1 with strategic investments and a focus shift towards high-value sectors.
Category: Healthcare
Rio Tinto (ASX:RIO) Announces Rincon Project Mineral Resources and Ore Reserves
Rio Tinto announces initial lithium resources and reserves for its Rincon Project in Argentina, with plans for enhanced production capacity.
HeraMED Limited (ASX:HMD) Advances Maternity Care Solutions
HeraMED Limited (ASX:HMD) announces key advancements in maternity care through its HeraCARE platform and forming strategic partnerships.
Syntara Limited (ASX:SNT) Addresses ASX Price Query
Syntara Limited addresses recent trading activity and plans to present interim data at the ASH Meeting.
Alpha HPA Limited (ASX:A4N) Provides Update on Project Progress
Alpha HPA Limited updates on project milestones and market developments across its HPA First Project and product offerings.
Anatara Lifesciences (ASX: ANR) Provides GaRP-IBS Trial Update
Anatara Lifesciences updates on its GaRP-IBS trial with promising recruitment numbers and anticipates results in early 2025.
4DMedical Limited (ASX:4DX) Unveils Groundbreaking CT:VQ Technology
4DMedical Limited (ASX:4DX) presents its innovative CT:VQ technology at RSNA 2024, poised to revolutionise lung health diagnostics.
Cynata Therapeutics Limited (ASX:CYP) Requests Trading Halt
Cynata Therapeutics Limited (ASX:CYP) has announced a trading halt pending a significant clinical trial update.
Acrux Limited (ASX:ACR) Receives FDA Approval for Nitroglycerin Ointment
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus Limited (ASX:PME) Co-Founders Sell Shares
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.